New platform maps the global journey of advanced therapy research
How does research on gene and cell therapies move from scientific discovery towards treatments, patents and policy? A new interactive platform developed at the House of Innovation lets users explore more than 900,000 research publications and see where that knowledge goes next.
Advanced therapy medicinal products (ATMPs) are treatments based on genes, cells or tissues. They include gene therapies, cell therapies and tissue-engineered products and may offer new treatment options for diseases where effective therapies are currently limited or unavailable.
Research in this rapidly developing field takes place across universities, hospitals and companies around the world. But understanding where countries have particular strengths (and what happens to research after it is published) can be difficult.
Yotam Sofer, Postdoctoral Researcher and Wallander Research Fellow at the House of Innovation, has developed the ATMP Research Platform to make that global landscape easier to explore.
The interactive platform maps more than 900,000 scientific publications from 192 countries published between 1990 and 2024. It allows users to explore researchers, institutions and collaborations and, crucially, follow connections between scientific research and clinical trials, patents, policy documents, clinical guidelines, news and blogs.
Following what happens after research is published
The platform makes it possible to look beyond traditional measures of research output and investigate how scientific knowledge travels towards potential use.
“The ATMP Map shows who produces advanced therapy research and where that knowledge goes next, including clinical trials, patents and policy. This helps us identify strengths and the parts of the path from discovery to treatment that need more support,” says Yotam Sofer.
Sweden offers one example of what the platform can reveal. The country has produced around 15,000 ATMP research papers and ranks 15th worldwide by publication volume. Over the past two decades, Sweden has ranked first globally in the quality of its research on DNA tailoring, a field that includes CRISPR gene editing, gene insertion and gene correction.
The map also reveals how Swedish research is used beyond academia. About one in four Swedish ATMP papers has been cited in a patent, while Swedish papers are cited in policy documents and clinical guidelines about twice as often as the global average.
The platform grew out of a national collaboration connected to NEXT-ATMP, bringing together Swedish universities, hospitals, industry and other innovation actors.
Participating organizations include Lund University, Karolinska Institutet, KTH Royal Institute of Technology, SSE, Uppsala University, University of Gothenburg, Karolinska University Hospital, Skåne University Hospital and ATMP Sweden, together with industrial partners including CCRM Nordic and BioLamina and other innovation actors and companies.
See how the ATMP Map works
On 12 November, Yotam Sofer will present the platform in an open online webinar hosted by ATMP Sweden.
During “Introducing the ATMPmap: A New Resource Delivering Insights into Sweden's ATMP Landscape”, Sofer will explain how he built the map, demonstrate how it can be used and discuss what its data reveal about Sweden's position in the global advanced therapies landscape.
The webinar takes place on Thursday, 12 November 2026, from 13:00 to 14:00 CET. It is open to researchers, companies, healthcare professionals and anyone interested in advanced therapies.
Registration: https://lnkd.in/dZ28vpPY
About the ATMP Research Platform
The ATMP Research Platform maps ATMP research worldwide and traces links to clinical trials, patents, policy documents, clinical guidelines, news, blogs and other forms of societal impact. Developed at the House of Innovation, Stockholm School of Economics, the platform covers research published between 1990 and 2024. The underlying data were extracted in May 2026.
Explore the platform: https://www.atmpmap.com/
Contacts
Research and platform
Yotam Sofer
Postdoctoral Researcher and Wallander Research Fellow
House of Innovation, Stockholm School of Economics
yotam.sofer@hhs.se
Research
Valentina Tartari
Jacob and Marcus Wallenberg Professor of Innovative and Sustainable Business Development
House of Innovation, Stockholm School of Economics
valentina.tartari@hhs.se
